The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Source:http://linkedlifedata.com/resource/pubmed/id/11535508
Blood
2001
Sep
15
98
6
1752-9
